Critically Ill Patients Clinical Trial
Official title:
Impact of Interventions on Admission SOFA Score on Clinical Outcomes of Critically Ill Patients
NCT number | NCT05790915 |
Other study ID # | HSD 2023 1 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | August 1, 2023 |
Est. completion date | March 31, 2024 |
Verified date | April 2024 |
Source | Hospital Sao Domingos |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Introduction: The SOFA score (Sequential Organ Function Assessment) and its derived measures, such as the Delta SOFA, are used worldwide to determine the severity and prognosis of critically ill patients. Objectives: The primary objective of this study was to assess the impact of standardized interventions on the six organ dysfunctions of SOFA score on outcomes of critically ill patients through the 48-hour delta SOFA with evaluation of the effectiveness of the interventions performed. Result will be correlated with the 28-day mortality. The secondary outcome measures comprised the evaluation of standardized interventions on ICU and hospital length of stay; vasopressor-free and ventilator-free days within the 28 days following ICU admission, through the effectiveness of interventions performed Uni and multivariate statistical analysis will be used to determine organ failures associated to outcome.
Status | Completed |
Enrollment | 849 |
Est. completion date | March 31, 2024 |
Est. primary completion date | January 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients aged above 18 years, - Lenght of ICU stay of at least 3 days. Exclusion Criteria: - Pregnant patients - End-of-life - Patients readmitted to the ICU in the same hospitalization |
Country | Name | City | State |
---|---|---|---|
Brazil | Hospital Sao Domingos | Sao Luis | MA |
Lead Sponsor | Collaborator |
---|---|
Hospital Sao Domingos |
Brazil,
Anami EH, Grion CM, Cardoso LT, Kauss IA, Thomazini MC, Zampa HB, Bonametti AM, Matsuo T. Serial evaluation of SOFA score in a Brazilian teaching hospital. Intensive Crit Care Nurs. 2010 Apr;26(2):75-82. doi: 10.1016/j.iccn.2009.10.005. Epub 2009 Dec 29. — View Citation
Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest. 1992 Jun;101(6):1481-3. doi: 10.1378/chest.101.6.1481. No abstract available. — View Citation
de Azevedo JR, Torres OJ, Beraldi RA, Ribas CA, Malafaia O. Prognostic evaluation of severe sepsis and septic shock: procalcitonin clearance vs Delta Sequential Organ Failure Assessment. J Crit Care. 2015 Feb;30(1):219.e9-12. doi: 10.1016/j.jcrc.2014.08.0 — View Citation
de Grooth HJ, Geenen IL, Girbes AR, Vincent JL, Parienti JJ, Oudemans-van Straaten HM. SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis. Crit Care. 2017 Feb 24;21(1):38. doi: 10.1186/s13054-017 — View Citation
Jones AE, Trzeciak S, Kline JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med. 2009 May;37(5):1649-54. doi: — View Citation
Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. W — View Citation
Soo A, Zuege DJ, Fick GH, Niven DJ, Berthiaume LR, Stelfox HT, Doig CJ. Describing organ dysfunction in the intensive care unit: a cohort study of 20,000 patients. Crit Care. 2019 May 23;23(1):186. doi: 10.1186/s13054-019-2459-9. — View Citation
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Proble — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Impact of standardized interventions in respiratory dysfunction on 48-hour delta SOFA with evaluation of the effectiveness of the interventions performed. | Lung protective ventilation: Tidal volume = 6 ml/kg; Plateau pressure < 28 mmHg; driving pressue < 16 cm H2O; Mechanical power < 16 Joules/min; Prevention of self-inflicted lung injury (P-SILI): ROX index > 4.8 and HACOR < 5. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with respiratory dysfunction and effective intervention / Number of patients with respiratory dysfunction X 100 |
48 hours | |
Primary | Impact of standardized interventions in hemodinamic dysfunction on 48-hour delta SOFA | SOSD (salvage, optimization, stabilization and de-escalation ) protocol; mean arterial pressoric taget of at least 65 mm Hg, Lactate serum level < 19 mg/dL. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hemodinamic dysfunction and effective intervention / Number of patients with hemodinamica dysfunction X 100 |
48 hour | |
Primary | Impact of standardized interventions in neurologic dysfunction on 48-hour delta SOFA | Image: cranial CT; Electroencephalografic monitoring and RASS Score between -1 and +1 The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with neurologic dysfunction and effective intervention / Number of patients with neurologic dysfunction X 100 |
48 hour | |
Primary | Impact of standardized interventions in hematologic dysfunction on 48-hour delta SOFA | Basic disease approach; avoid drugs that interfere with coagulation; Platelet transfusion in case of hemohhage; DDAVP when indicated. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hematologic dysfunction and effective intervention / Number of patients with hematologic dysfunction X 100 |
48 hour | |
Primary | Impact of standardized interventions iin renal dysfunction on 48-hour delta SOFA | Avoid nephotoxic drugs; Mantain mean arterial blood pressure > 65 mmHg The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with renal dysfunction and effective intervention / Number of patients with renal dysfunction X 100 |
48 hour | |
Primary | Impact of standardized interventions in hepatic dysfunction on 48-hour delta SOFA | Avoid hepatotoxic drugs;basic disease approach The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hepatic dysfunction and effective intervention / Number of patients with hepatic dysfunction X 100 |
48 hour | |
Secondary | Impact of standardized interventions in respiratory dysfunction on ICU length of stay | Lung protective ventilation: Tidal volume 6 ml/kg; Pateau pressure < 28 mmHg; driving pressue < 16 cm H2O; Mechanical power < 16 Joules/min; Prevention of self-inflicted lung injury (P-SILI): ROX index > 4.8 and HACOR < 5. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with respiratory dysfunction and effective intervention / Number of patients with respiratory dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions in hemodinamic dysfuction on ICU length of stay | SOSD (salvage, optimization, stabilixation and de-escalation ) protocol; mean arterial pressoric taget of at least 65 mm Hg, Lactate serum level < 19 mg/dL. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hemodinamic dysfunction and effective intervention / Number of patients with hemodinamic dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions in neurologic dysfunction on ICU length of stay | Image: cranial CT; Electroencephalografic monitoring and RASS Score between -1 and +1 The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with neurologic dysfunction and effective intervention / Number of patients with neurologic dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions in hematologic dysfunction on ICU length of stay | Basic disease approach; avoid drugs that interfere with coagulation; Platelet transfusion in case of hemohhage; DDAVP when indicated. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hematologic dysfunction and effective intervention / Number of patients with hematologic dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions iin renal dysfunction on ICU length of stay | Avoid nephotoxic drugs; Mantain mean arterial blood pressure > 65 mmHg The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with renal dysfunction and effective intervention / Number of patients with renal dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions in hepatic dysfunction on ICU length of stay | Avoid hepatotoxic drugs;basic disease approach The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hepatic dysfunction and effective intervention / Number of patients with hepatic dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions in respiratory dysfunction on vasopressor-free days | Lung protective ventilation: Tidal volume 6 ml/kg; Pateau pressure < 28 mmHg; driving pressue < 16 cm H2O; Mechanical power < 16 Joules/min; Prevention of self-inflicted lung injury (P-SILI): ROX index > 4.8 and HACOR < 5. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with respiratory dysfunction and effective intervention / Number of patients with respiratory dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions in hemodinamic dysfuction on vasopressor-free days | SOSD (salvage, optimization, stabilixation and de-escalation ) protocol; mean arterial pressoric taget of at least 65 mm Hg, Lactate serum level < 19 mg/dL. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hemodinamic dysfunction and effective intervention / Number of patients with hemodinamic dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions in neurologic dysfunction on vasopressor-free days | Image: cranial CT; Electroencephalografic monitoring and RASS Score between -1 and +1 The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with neurologic dysfunction and effective intervention / Number of patients with neurologic dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions in hematologic dysfunction on vasopressor-free days | Basic disease approach; avoid drugs that interfere with coagulation; Platelet transfusion in case of hemohhage; DDAVP when indicated. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hematologic dysfunction and effective intervention / Number of patients with hematologic dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions iin renal dysfunction on vasopressor-free days | Avoid nephotoxic drugs; Mantain mean arterial blood pressure > 65 mmHg The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with renal dysfunction and effective intervention / Number of patients with renal dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions in hepatic dysfunction on vasopressor-free days | Avoid hepatotoxic drugs;basic disease approach The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hepatic dysfunction and effective intervention / Number of patients with hepatic dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions in respiratory dysfunction on ventilator-free days | Lung protective ventilation: Tidal volume 6 ml/kg; Pateau pressure < 28 mmHg; driving pressue < 16 cm H2O; Mechanical power < 16 Joules/min; Prevention of self-inflicted lung injury (P-SILI): ROX index > 4.8 and HACOR < 5. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with respiratory dysfunction and effective intervention / Number of patients with respiratory dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions in hemodinamic dysfuction on ventilator-free days | SOSD (salvage, optimization, stabilixation and de-escalation ) protocol; mean arterial pressoric taget of at least 65 mm Hg, Lactate serum level < 19 mg/dL. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hemodinamic dysfunction and effective intervention / Number of patients with hemodinamic dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions in neurologic dysfunction on ventilator-free days | Image: cranial CT; Electroencephalografic monitoring and RASS Score between -1 and +1 The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with neurologic dysfunction and effective intervention / Number of patients with neurologic dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions in hematologic dysfunction on ventilator-free days | Basic disease approach; avoid drugs that interfere with coagulation; Platelet transfusion in case of hemohhage; DDAVP when indicated. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hematologic dysfunction and effective intervention / Number of patients with hematologic dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions iin renal dysfunction on ventilator-free days | Avoid nephotoxic drugs; Mantain mean arterial blood pressure > 65 mmHg The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with renal dysfunction and effective intervention / Number of patients with renal dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions in hepatic dysfunction on ventilator-free days | Avoid hepatotoxic drugs;basic disease approach The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hepatic dysfunction and effective intervention / Number of patients with hepatic dysfunction X 100 |
28 days | |
Secondary | Impact of standardized interventions in respiratory dysfunction on hospital length of stay | Lung protective ventilation: Tidal volume 6 ml/kg; Pateau pressure < 28 mmHg; driving pressue < 16 cm H2O; Mechanical power < 16 Joules/min; Prevention of self-inflicted lung injury (P-SILI): ROX index > 4.8 and HACOR < 5. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with respiratory dysfunction and effective intervention / Number of patients with respiratory dysfunction X 100 |
60 days | |
Secondary | Impact of standardized interventions in hemodinamic dysfuction on hospital length of stay | SOSD (salvage, optimization, stabilixation and de-escalation ) protocol; mean arterial pressoric taget of at least 65 mm Hg, Lactate serum level < 19 mg/dL. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hemodinamic dysfunction and effective intervention / Number of patients with hemodinamic dysfunction X 100 |
60 days | |
Secondary | Impact of standardized interventions in neurologic dysfunction on hospital length of stay | Image: cranial CT; Electroencephalografic monitoring and RASS Score between -1 and +1 The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with neurologic dysfunction and effective intervention / Number of patients with neurologic dysfunction X 100 |
60 days | |
Secondary | Impact of standardized interventions in hematologic dysfunction on hospital length of stay | Basic disease approach; avoid drugs that interfere with coagulation; Platelet transfusion in case of hemohhage; DDAVP when indicated. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hematologic dysfunction and effective intervention / Number of patients with hematologic dysfunction X 100 |
60 days | |
Secondary | Impact of standardized interventions in renal dysfunction on hospital length of stay | Avoid nephotoxic drugs; Mantain mean arterial blood pressure > 65 mmHg The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with renal dysfunction and effective intervention / Number of patients with renal dysfunction X 100 |
60 days | |
Secondary | Impact of standardized interventions in hepatic dysfunction on hospital length of stay | Avoid hepatotoxic drugs;basic disease approach The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hepatic dysfunction and effective intervention / Number of patients with hepatic dysfunction X 100 |
60 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04045366 -
Impact of Capillary Leak and Hypoalbuminemia on PK/PD of Anidulafungin and Caspofungin in Critically Ill Patients
|
||
Completed |
NCT01411553 -
ECG Leadwires: Disposable Versus Cleaned, Reusable
|
N/A | |
Completed |
NCT00288743 -
Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study
|
Phase 2 | |
Recruiting |
NCT03529617 -
Pharmacokinetics of Liposomal Amphotericin B in Critically Ill vs. Non-critically Ill Hematological Patients: Exploration of Covariates
|
||
Not yet recruiting |
NCT05564975 -
Construction and Application of Pressure Injury Risk Prediction Model for Critically Ill Patients
|
||
Recruiting |
NCT06234787 -
Continuous Subcutaneous Glucose Monitoring in Critical Patients
|
||
Completed |
NCT02198950 -
Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis
|
||
Recruiting |
NCT01317381 -
ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill
|
Phase 4 | |
Completed |
NCT00470821 -
Oral Melatonin in Critically Ill High-risk Patients
|
Phase 4 | |
Completed |
NCT00460252 -
Tight Glycemic Control by eMPC Algorithm in Medical ICU Patients.
|
N/A | |
Recruiting |
NCT06049979 -
Correlation Between Intestinal Blood Flow and Intestinal Dysfunction in Critically Ill Patients
|
||
Active, not recruiting |
NCT04793568 -
Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP Study
|
Phase 2 | |
Recruiting |
NCT05458687 -
Traditional Chinese Medicine for Complications in Critically Ill Patients
|
N/A | |
Completed |
NCT01963013 -
Non-returning Catheter Valve for Reducing CAUTI
|
N/A | |
Completed |
NCT01794468 -
A New Monitor to Measure Dermal Blood Flow in Critically Ill Patients: a Preliminary Study
|
N/A | |
Completed |
NCT03469882 -
High Protein Intake and Early Exercise in Adult Intensive Care Patients
|
N/A | |
Recruiting |
NCT04962204 -
Virtual Visitation in Intensive Care Unit Study
|
N/A | |
Completed |
NCT03205592 -
Ultrasound Assessment of Residual Gastric Content in Critically Ill Patients
|
||
Recruiting |
NCT01995565 -
Regional Cerebral Hemodynamics Related to Global Hemodynamics
|
N/A | |
Completed |
NCT00143494 -
The Estimation of Abdominal Pressure by the Bladder and Gastric Pressure
|
N/A |